REFERENCES
- Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC JR. Color Atlas and Textbook of Diagnostic Microbi-ology, Fifth edition 1997: 269.
- CLSI. Performance Standards for Antimicrobial Disk Sus-ceptibility Tests; Approved Standard-Ninth Edition. M2-A9, 2006.
- Livermore DM, Winstanley TG, Shannon KP. Interpretative reading: recognizing the unusual and inferring resistance mech-anism from resistance phenotypes. J Antimicrob Chemother 2001; 48, Suppl, S 1: 87-102.
- Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare? Clin Infect Dis 2002; 34: 634-640.
- Coban AY, Ekinci B, Durupinar B. A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates. Chemotherapy 2004; 50: 22–26.
- Lomovskaya O, Warren MS, Lee A, Galazzo J, Fronko R, Lee M, et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001; 45: 105–116.
- Cetinkaya E, Coban AY, Durupinar B. Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coil, Acinetobacter baumannii and Staphylococcus aureus. Mikro-biyol Bul 2008; 42: 553–561.
- Bohnert JA, Kern WV. Selected arylpiperazines are capa-ble of reversing multidrug resistance in Escherichia coil overex-pressing RND efflux pumps. Antimicrob Agents Chemother 2005; 49: 849–852.
- Schumacher A, Steinke P, Bohnert JA, Akova M, Jonas D, Kern WV. Effect of 1-(1-naphthylmethyfl-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibil-ity in clinical isolates of Enterobacteriaceae other than Es-cherichia coil. J Antimicrob Chemother 2006; 57: 344–348.
- Kern WV, Steinke P, Schumacher A, Schuster S, von Baum H, Bohnert JA. Effect of 1-(1-naphthylmethyfl-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug sus-ceptibility in clinical isolates of Escherichia coil. J Antimicrob Chemother 2006; 57: 339–343.
- Bina XR, Philippart JA, Bina JE. Effect of the efflux pump inhibitors 1-(1-naphthylmethyfl-piperazine and phenyl-arginine-13-naphthylamide on antimicrobial susceptibility and virulence factor production in Vibrio cholerae. J Antimicrob Chemother 2009; 63: 103–108.
- Pannek S, Higgins PG, Steinke P, Jonas D, Akova M, Bohnert JA, et al. Multidrug efflux inhibition in Acinetobacter baumanni: comparison between 1-(1-naphthylmethyfl-piperazine and phenyl-arginine-b-naphthylamide. J Antimicrob Chemother 2006; 57: 970–974.
- Hannula M, Hanninen ML. Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coil. J Med Micro-biol 2008; 57: 851–855.
- Bean DC, Wareham DW. Paradoxical effect of 1-(1-naph-thylmethyfl-piperazine on resistance to tetracyclines in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 2009; 63: 349–352.